NCT02651272View on ClinicalTrials.gov

Macitentan in Pulmonary Hypertension of Sickle Cell Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions

Pulmonary HypertensionSickle Cell Disease

Interventions

DRUG

macitentan

10mg macitentan tablets

Trial Locations (1)

02118

Boston University School of Medicine, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Actelion

INDUSTRY

lead

Boston University

OTHER